
Please try another search
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Name | Age | Since | Title |
---|---|---|---|
Olivier Taelman | 53 | 2019 | CEO & Executive Director |
Daniel G. Wildman | 68 | 2023 | Independent Non-Executive Director |
Rita Faye Johnson-Mills | 65 | 2021 | Independent Non-Executive Director |
Virginia M. Kirby | 68 | 2022 | Independent Non-Executive Director |
Robert Taub | 78 | 2009 | Co-Founder & Chairman |
Jurgen Hambrecht | 79 | 2020 | Independent Non-Executive Director |
Kevin L. Rakin | 64 | 2016 | Independent Non-Executive Director |
Pierre Gianello | 67 | 2018 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review